TY - STD TI - Ministry of Health (1997) National diabetes survey. http://www.mhlw.go.jp/toukei/kouhyo/indexkk_4_1.html. Accessed 20 Mar 2015. UR - http://www.mhlw.go.jp/toukei/kouhyo/indexkk_4_1.html ID - ref1 ER - TY - STD TI - Ministry of Health, Labour and Welfare (2012) National Health and Nutrition Survey. http://www.mhlw.go.jp/bunya/kenkou/eiyou/h24-houkoku.html. Accessed 20 Mar 2015. UR - http://www.mhlw.go.jp/bunya/kenkou/eiyou/h24-houkoku.html ID - ref2 ER - TY - JOUR AU - Goto, A. AU - Goto, M. AU - Noda, M. AU - Tsugane, S. PY - 2013 DA - 2013// TI - Incidence of type 2 diabetes in Japan: a systematic review and meta-analysis JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0074699 DO - 10.1371/journal.pone.0074699 ID - Goto2013 ER - TY - JOUR AU - Neville, S. E. AU - Boye, K. S. AU - Montgomery, W. S. AU - Iwamoto, K. AU - Okamura, M. AU - Hayes, R. P. PY - 2009 DA - 2009// TI - Diabetes in Japan: a review of disease burden and approaches to treatment JO - Diabetes Metab Res Rev. VL - 25 UR - https://doi.org/10.1002/dmrr.1012 DO - 10.1002/dmrr.1012 ID - Neville2009 ER - TY - JOUR AU - Fukushima, M. AU - Suzuki, H. AU - Seino, Y. PY - 2004 DA - 2004// TI - Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes JO - Diabetes Res Clin Pract VL - 66 UR - https://doi.org/10.1016/j.diabres.2003.11.024 DO - 10.1016/j.diabres.2003.11.024 ID - Fukushima2004 ER - TY - JOUR AU - Iwahashi, H. AU - Okauchi, O. AU - Ryo, M. AU - Noguchi, M. AU - Morita, S. AU - Kishida, K. PY - 2012 DA - 2012// TI - Insulin-secretion capacity in normal glucose tolerance, impaired glucose tolerance, and diabetes in obese and non-obese Japanese patients JO - J Diabetes Investig. VL - 3 UR - https://doi.org/10.1111/j.2040-1124.2011.00180.x DO - 10.1111/j.2040-1124.2011.00180.x ID - Iwahashi2012 ER - TY - JOUR AU - Moller, J. B. AU - Pedersen, M. AU - Tanaka, H. AU - Ohsugi, M. AU - Overgaard, R. V. AU - Lynge, J. PY - 2014 DA - 2014// TI - Body composition is the main determinant for the difference in type 2 diabetes pathophysiology between Japanese and Caucasians JO - Diabetes Care VL - 37 UR - https://doi.org/10.2337/dc13-0598 DO - 10.2337/dc13-0598 ID - Moller2014 ER - TY - JOUR PY - 2004 DA - 2004// TI - Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies JO - Lancet VL - 363 UR - https://doi.org/10.1016/S0140-6736(03)15268-3 DO - 10.1016/S0140-6736(03)15268-3 ID - ref8 ER - TY - JOUR AU - Nisal, K. AU - Kela, R. AU - Khunti, K. AU - Davies, M. J. PY - 2012 DA - 2012// TI - Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus JO - BMC Med VL - 10 UR - https://doi.org/10.1186/1741-7015-10-152 DO - 10.1186/1741-7015-10-152 ID - Nisal2012 ER - TY - JOUR AU - Seino, Y. AU - Min, K. W. AU - Niemoeller, E. AU - Takami, A. PY - 2012 DA - 2012// TI - EFC10887 GETGOAL-L Asia Study Investigators. Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia) JO - Diabetes Obes Metab VL - 14 UR - https://doi.org/10.1111/j.1463-1326.2012.01618.x DO - 10.1111/j.1463-1326.2012.01618.x ID - Seino2012 ER - TY - JOUR AU - Rosenstock, J. AU - Hanefeld, M. AU - Shamanna, P. AU - Min, K. W. AU - Boka, G. AU - Miossec, P. PY - 2014 DA - 2014// TI - Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S) JO - J Diabetes Complications VL - 28 UR - https://doi.org/10.1016/j.jdiacomp.2014.01.012 DO - 10.1016/j.jdiacomp.2014.01.012 ID - Rosenstock2014 ER - TY - JOUR AU - Meier, J. J. PY - 2012 DA - 2012// TI - GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus JO - Nat Rev Endocrinol. VL - 8 UR - https://doi.org/10.1038/nrendo.2012.140 DO - 10.1038/nrendo.2012.140 ID - Meier2012 ER - TY - JOUR AU - Scheen, A. J. PY - 2016 DA - 2016// TI - Dulaglutide (LY-2189265) for the treatment of type 2 diabetes JO - Expert Rev Clin Pharmacol. VL - 9 UR - https://doi.org/10.1586/17512433.2016.1141046 DO - 10.1586/17512433.2016.1141046 ID - Scheen2016 ER - TY - JOUR AU - Seino, Y. AU - Ikeda, Y. AU - Niemoeller, E. AU - Watanabe, D. AU - Takagi, H. AU - Yabe, D. PY - 2015 DA - 2015// TI - Efficacy and safety of lixisenatide in Japanese patients with type 2 diabetes insufficiently controlled with basal insulin ± sulphonylurea: a subanalysis of the GetGoal-L-Asia study JO - Horm Metab Res VL - 47 UR - https://doi.org/10.1055/s-0035-1549875 DO - 10.1055/s-0035-1549875 ID - Seino2015 ER - TY - JOUR AU - Onishi, Y. AU - Niemoeller, E. AU - Ikeda, Y. AU - Takagi, H. AU - Yabe, D. AU - Seino, Y. PY - 2015 DA - 2015// TI - Efficacy and safety of lixisenatide in Japanese patients with type 2 diabetes mellitus inadequately controlled by sulfonylurea with or without metformin: subanalysis of GetGoal-S JO - J Diabetes Invest. VL - 6 UR - https://doi.org/10.1111/jdi.12275 DO - 10.1111/jdi.12275 ID - Onishi2015 ER - TY - JOUR AU - Schmidt, L. J. AU - Habacher, W. AU - Augustin, T. AU - Krahulec, E. AU - Semlitsch, T. PY - 2014 DA - 2014// TI - A systematic review and meta-analysis of the efficacy of lixisenatide in the treatment of patients with type 2 diabetes JO - Diabetes Obes Metab VL - 16 UR - https://doi.org/10.1111/dom.12269 DO - 10.1111/dom.12269 ID - Schmidt2014 ER - TY - JOUR AU - Seino, Y. AU - Takami, A. AU - Boka, G. AU - Niemoeller, E. AU - Raccah, D. PY - 2014 DA - 2014// TI - PDY6797 investigators. Pharmacodynamics of the glucagon-like peptide-1 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulfonylureas with/without metformin JO - Diabetes Obes Metab VL - 16 UR - https://doi.org/10.1111/dom.12276 DO - 10.1111/dom.12276 ID - Seino2014 ER - TY - JOUR AU - Wang, J. S. AU - Tu, S. T. AU - Lee, I. T. AU - Lin, S. D. AU - Lin, S. Y. AU - Su, S. L. PY - 2011 DA - 2011// TI - Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring JO - Diabetes Metab Res Rev. VL - 27 UR - https://doi.org/10.1002/dmrr.1149 DO - 10.1002/dmrr.1149 ID - Wang2011 ER - TY - JOUR AU - Shichiri, M. AU - Kishikawa, H. AU - Ohkubo, Y. AU - Wake, N. PY - 2000 DA - 2000// TI - Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients JO - Diabetes Care VL - 23 ID - Shichiri2000 ER - TY - JOUR AU - Bonora, E. PY - 2002 DA - 2002// TI - Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives JO - Int J Clin Pract Suppl. VL - 129 ID - Bonora2002 ER - TY - JOUR AU - Standl, E. AU - Schell, O. AU - Ceriello, A. PY - 2011 DA - 2011// TI - Postprandial hyperglycemia and glycemic variability: should we care JO - Diabetes Care VL - 34 UR - https://doi.org/10.2337/dc11-s206 DO - 10.2337/dc11-s206 ID - Standl2011 ER - TY - JOUR AU - Nakanishi, S. AU - Yoneda, M. AU - Maeda, S. PY - 2013 DA - 2013// TI - Impact of glucose excursion and mean glucose concentration in oral glucose-tolerance test on oxidative stress among Japanese Americans JO - Diabetes Metab Syndr Obes. VL - 6 ID - Nakanishi2013 ER - TY - JOUR AU - Pitocco, D. AU - Tesauro, M. AU - Alessandro, R. AU - Ghirlanda, G. AU - Cardillo, C. PY - 2013 DA - 2013// TI - Oxidative stress in diabetes: implications for vascular and other complications JO - Int J Mol Sci VL - 14 UR - https://doi.org/10.3390/ijms141121525 DO - 10.3390/ijms141121525 ID - Pitocco2013 ER - TY - JOUR AU - Mo, Y. AU - Zhou, J. AU - Li, M. AU - Wang, Y. AU - Bao, Y. AU - Ma, X. PY - 2013 DA - 2013// TI - Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients JO - Cardiovasc Diabetol. VL - 12 UR - https://doi.org/10.1186/1475-2840-12-15 DO - 10.1186/1475-2840-12-15 ID - Mo2013 ER - TY - JOUR AU - Pfeffer, M. A. AU - Claggett, B. AU - Diaz, R. AU - Dickstein, K. AU - Gerstein, H. C. PY - 2015 DA - 2015// TI - Lixisenatide in patients with type 2 diabetes and coronary syndrome JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1509225 DO - 10.1056/NEJMoa1509225 ID - Pfeffer2015 ER - TY - JOUR AU - Stratton, I. M. AU - Adler, A. I. AU - Neil, A. W. PY - 2000 DA - 2000// TI - Association of glycaemia with macrovascular and microvascular complication of type 2 diabetes (UKPDS 35): prospective observational study JO - BMJ VL - 321 UR - https://doi.org/10.1136/bmj.321.7258.405 DO - 10.1136/bmj.321.7258.405 ID - Stratton2000 ER - TY - JOUR AU - Anton, S. D. AU - Karabetian, C. AU - Naugle, K. AU - Buford, T. W. PY - 2013 DA - 2013// TI - Obesity and diabetes as accelerators of functional decline; can lifestyle interventions maintain functional status in high risk older adults? JO - Exp Gerontol VL - 48 UR - https://doi.org/10.1016/j.exger.2013.06.007 DO - 10.1016/j.exger.2013.06.007 ID - Anton2013 ER - TY - JOUR AU - Umegaki, H. PY - 2015 DA - 2015// TI - Sarcopenia and diabetes: hyperglycemia is a risk factor for age-associated muscle mass and functional reduction JO - J Diabetes Investig. VL - 6 UR - https://doi.org/10.1111/jdi.12365 DO - 10.1111/jdi.12365 ID - Umegaki2015 ER -